ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL..

Transcription

1 PROVINCE OF BRITISH COLUMBIA Order la Council No. ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL.. 1, Approved and Ordered NOV arm. Lieutenant Governor' Executive Council Chambers, Victoria On the recommendation of the undersigned, the Lieutenant Governor, by and with the advice and consent of the Executive Council, orders that approval is given to the following: (a) the attached Resolution of the Council of the College of Pharmacists of British Columbia, dated June 12, 1998, amending B.C. Reg 9/98, the Drug Schedules Regulation; (b) the attached Resolution of the Council of the College of Pharmacists of British Columbia dated June 13, 1998, amending the Drug Schedules Regulation referred to in paragraph (a) of this Order; and (c) the attached Resolution of the Council of the College of Pharmacists of British Columbia dated August 24, 1998, further amending the Drug Schedules Regulation referred to in paragraph (a) of this Order. Minister of Health a d Minister Resibonsible for Seniors Presiding Member of the Executive Council Authority under which Order is made: (IVs part is for administrative purposes only and is not part of the Order) Act and section:- Pharmacists, Pharmacy Operations and Drug Scheduling Act, section 64 Other (specify):- C 3S/9 S K:1 PPODSMOICTRUGORD.JUL

2 Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 24th day of August RESOLVED THAT: In accordance with the authority established in Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedule by regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda J. Lyt Registrar.Sc.( hr.), R.Ph. oteu-15/ar NATRACBGENERAL\24AUG98C.WPD Our mission: Safe and effective pharmacy practice outcomes for the people of British Columbia.

3 SCHEDULE That the Drug Schedule be amended by the deletion of: 1 Vaccines (except brucellosis, equine influenza, leptospirosis, mink plasmacytosis and rabies) And by the addition of: 1 Vaccines (brucellosis, equine influenza, leptospirosis, mink plasmacytosis and rabies) 2 Vaccines (except brucellosis, equine influenza, leptospirosis, mink plamacytosis and rabies) oteu-15/ar N:\TRACI\GENERAL\24AUG98C.WPD Our mission: Safe and effective pharmacy practice outcomes for the people of British Columbia.

4 Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 13th day of June RESOLVED THAT: In accordance with the authority established in Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R. S. B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedules by regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda J. Lyt Registrar c.(phr.), R.Ph. num-15/tind ,981) RES

5 SCHEDULE That, effective immediately, the Drug Schedules be amended, according to the 13 June 1998 resolution of Council, by the deletion of the following: 2 Bioflavonoids (in concentrations of more than 200 mg per dosage unit) 3 Charcoal (activated) And by the addition of: 2 Charcoal (activated) when sold as a poisoning antidote Rationale: These amendments incorporate amendments developed by the National Drug Scheduling Advisory Committee. ohm- I 5/tmd I JI 11,981) RES

6 Resolution of the Council of the College of Pharmacists of British Columbia ("the Council"), made at Vancouver, British Columbia, the 12th day of June RESOLVED THAT: In accordance with the authority established in Section 64 of The Pharmacists, Pharmacy Operations and Drug Scheduling Act, R.S.B.C. 1996, c. 363 of British Columbia, the Council amends the Drug Schedules by regulation as set out in the attached schedule, subject to the approval of the Lieutenant Governor in Council. Certified a true copy Linda J. L /B.Sc.( Registrar I &NIL.), R.Ph. okm- I 5/tmd ( ) RES

7 SCHEDULE That, effective immediately, the Drug Schedules be amended as follows, according to the 12 June 1998 resolution of Council. I. In the introduction section "Unscheduled (Nonpharmacy Sale)": Delete the following paragraph: If any one ingredient of a combination product falls under Schedule I, for example, the entire product is considered to be a Schedule I drug. Similarly, if one ingredient of a combination product falls under Schedule II, the product must not be accessible to the public. 2. On every page where it is listed: Delete the footer: Prescription not required if sold for veterinary use. And add the footer: v Prescription not required if sold for veterinary use, provided that the product is labelled by the manufacturer "for agricultural use only" or "for veterinary use only." 3. And by the deletion of the following: 2 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit or rectal preparations containing 150 mg or less per dosage unit) 3 Acetylsalicylic acid and its salts (except in packages containing less than 51 dosage units of 325 mg or less) I Adrenocortical hormones and their salts and derivatives, (except hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 0.5% hydrocortisone in preparations for topical use on the skin) v 3 Aloe vera latex, its extracts and derivatives (except aloin) (dosage forms for systemic use containing more than 300 mg or more per dosage unit) I Androisoxazole v I Androstanolone v 1 Antipyrine (except preparations for topical use) V Antipyrine (except otic preparations) 3 Antipyrine (tor otic use) I Azatidine and its salts Bengal Rose (see Rose Bengal) 2 Benzocaine and its salts (for parenteral or ophthalmic use, or in products marketed for topical application on mucous membranes for children under 2 years of age) Bcnzoyl peroxide (in concentrations greater than 5 per cent or when sold in combination with another medicinal ingredient) 1 Bolandiol and its derivatives v oteti- I Sitind ) RI. S Our mission: Sale and elleclive pharmacy praclice macaws for the people of British ( 'alumina.

8 SCHEDULE (continued) Page 2 1 Bolasterone V 1 Bolazine v 1 Boldenone and its derivatives V 1 Bolenol V 1 Calusterone V 1 Cetirizine and its salts (when sold in concentrations greater than 8.5 mg cetirizine base per dosage unit) 1 Clostebol and its derivatives V 1 Clotrimazole and its salts (except preparations for topical and vaginal use) 1 Cyproterone and its derivatives V 1 Diethylstilbestrol and its derivatives 1 Dimethylsulfoxide I Drostanolone and its derivatives V Enestebol V Epitiostanol V 1 Ethylestrenol V 1 Etoposide 1 Fluoxymesterone V I Formebolone 1 Furazabol V 1 Gonadotropins, serum (human) 2 Gramicidin (for ophthalmic use) 1 4-Hydroxy-19-nortestosterone and its derivatives V I lodochlorohydroxyquin (except in preparations for topical use on the skin) 1 Ivermectin (except when sold or recommended for intramuscular administration into horses or for administration to dogs) v I Lanzoprazole and its salts 2 Lindane ( scabicide) I Mebolazine v I Megestrol and its derivatives v I Mesabolone v I Mesterolone v I Metandienone v I Metenolone and its derivatives " I Methandriol v I Meth, testosterone and its derivatives v I Met.-.iolone v 1 Mibolerone 1 Miconazole and its salts (except in preparations for topical and vaginal use) 3 Mineral tar (except shampoos with concentrations less than 5%) I Nandrolone and its derivatives V I Nicotine and its salts (except in natural substances) when sold in a dosage form containing greater than the equivalent of 4 mg of nicotine or when contained in oteu- I 5/Imd ) RI.S Our 1111ASUM: Sufi' and effective pharmacy practice outcomes for the people of British (.olumbia.

9 SCHEDULE (continued) Page 3 transdermal patches with delivery rates of greater than 22 mg/day 2 Nitroglycerin (sublingual immediate release dosage forms ) I Nitroglycerin (except for sublingual immediate release dosage forms) I Norboletone 1 Norclostebol and its derivatives v 1 Norethandrolone I Oxabolone and its derivatives v I Oxandrolone 1 Oxymesterone 2 Oxymetazoline (in nasal preparations for pediatric use) I Oxymetholone v I Penicillin and its salts and derivatives (except amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, nafcillin, oxacillin and ticarcillin and their salts and derivatives) V I Pilocarpine and its salts (in preparations for ophthalmic use) 2 Pinaverium and its salts 2 Polymixin, and its salts and derivatives (for ophthalmic use) I Prasterone v I Quinbolone I Ranitidine and its salts (except oral tablets in strengths 75 mg or less) Sex hormones, except those listed in Part II of the Schedule to Part G of the Regulations to the Food and Drugs Act v 2 Sodium tetradecylsulfate I Stanozolol I Stenbolone and its derivatives v Stramonium, its preparations, its extracts, and its compounds I Tacrine and its salts I Tenidap and its salts 1 Testosterone and its derivatives v 1 Tetracycline and its salts and derivatives (except doxycycline when sold for intramuscular administration in caged birds) v I Tibolone v I Tioconazole and its salts (except in preparations for topical and vaginal use in humans) " 3 Tioconazole and its salts (in preparations for topical and vaginal use) I Tiomesterone V For list of exceptions, refer to page 25 of "Extracts from Regulations to the Food and Drugs Act" in the Information File Binder of u-15/11w g1) RES - Corrected 21 Jubb I 99g Our mission: Safe and eftective pharmacy practice outcomes fiir the people of British (Wumbia.

10 SCHEDULE (continued) Page 4 1 Trenbolone and its derivatives v 1 Tretinoin (Vitamin A acid) 1 Tylosin and its salts and derivatives (except when sold for the treatment of chronic colitis in dogs) v 1 Urofollitropin (human) I Vaccines 1 Zeranol 4. And by the addition of the following in alphabetical order: 1 Acetylsalicylic acid and its salts (in oral preparations containing 80 mg or less per dosage unit in containers with more than 24 dosage units per container) 2 Acetylsalicylic acid and its salts (in or;.i preparations containing 80 mg or less per dosage unit in child-resistant containers with 24 or less dosage units per container or rectal preparations containing 150 mg or less per dosage unit) 3 Acetylsalicylic acid and its salts (except in packages containing less than 51 dosage units of 325 mg or less per dosage unit) 1 Adrenocortical hormones and their salts and derivatives (except hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 0.5% or less hydrocortisone in preparations for topical use on the skin) V 3 Aloe vera latex, its extracts and derivatives (except aloin) (dosage forms for systemic use containing more than 300 mg per dosage unit) 1 Androisoxazole 1 Androstanolone 1 Antipyrine (except preparations for topical or otic use) V 2 Antipyrine for topical use only 3 Antipyrine for otic use only 1 Azatadine and its salts 3 l3enzocaine and its salts (in products marketed for topical application on mucous membranes for children under 2 years of age) 2 Benzocaine and its salts (for parenteral or ophthalmic use) I Benzoyl peroxide (in concentrations greater than 5% or when sold in combination with another medicinal ingredient) I 13olandiol and its derivatives 1 13olasterone 1 Bolazine 1 Boldenone and its derivatives I l3olenol I Calusterone 1 Cetirizine and its salts (when sold in concentrations of 10 mg equivalent to greater than 8.5 mg cetirizine base per dosage unit) 1 Clostebol and its derivatives tem- I sitrrid 0111 II.981) RI.S Our mission: Sale and effective pharmacy practice outcomes for the people of British (.olumbia.

11 SCHEDULE (continued) Page 5 1 Clotrimazole and its salts (except preparations for topical or vaginal use) 1 Cyproterone and its derivatives 1 Diethylstilbestrol and its derivatives 1 Dimethyl sulfoxide 1 Drostanolone and its derivatives 1 Enestebol 1 Epitiostanol 1 Ethylestrenol I Etoposide and its derivatives 1 Fluoxymesterone 1 Formebolone 1 Furazabol 1 Gonadotropin, serum (human) 2 Gramicidin and its salts and derivatives (for ophthalmic use) I Hydrocortisone (as a single ingredient in topical preparations in concentrations greater than 0.5%) 1 Hydrocortisone acetate (as a single ingredient in topical preparations in concentrations greater than 0.5%) 1 4-Hydroxy-19-nortestosterone and its derivatives 1 lodochlorhydroxyquin (except in preparations for topical use on the skin) 1 Ivermectin v (the exemption from requiring a prescription if sold for veterinary use does not apply when sold or recommended for intramuscular administration into horses or for administration to dogs) 1 Lansoprazole and its salts 2 Lindane 1 Mebolazine 1 Megestrol and its derivatives I Mesabolone I Mesterolone I Metandienone I Metenolone and its derivatives I Methandriol I Methvltestosterone and its derivatives I Metribolone I Miholerone I Miconazole and its salts (except in preparations for topical or vaginal use) 3 Mineral tar (except shampoos with concentrations of less than 5%) I Nandrolone and its derivatives I Nicotine and its salts (except in natural substances) when sold as a chewing gum containing more than 4 mg of nicotine per dosage unit, or when sold as a transdermal patch with a delivery rate of more than the equivalent of 22 mg of nicotine per day 2 Nitroglycerin (immediate-release sublingual dosage forms) 1 Nitroglycerin (except for immediate-release sublingual dosage forms) NACU- I 5/und M x1) RFS Our mission: Sale and ellective pharmacy practice outcomes/or the people of British (.olumbia.

12 SCHEDULE (continued) Page 6 1 Norboletone 1 Norclostebol and its derivatives 1 Norethandrolone 1 Oxabolone and its derivatives 1 Oxandrolone I Oxymesterone 2 Oxymetazoline and its salts (in nasal preparations for pediatric use) 1 Oxymetholone 1 Penicillin and its salts and derivatives (the exemption from requiring a prescription if sold for veterinary use does not apply to amoxicillin, ampicillin, azlocillin, benzathine penicillin, carbenicillin, cloxacillin, dicloxacillin, hetacillin, mecillinam, methicillin, mezlocillin, naf'cillin, oxacillin and ticarcillin and their salts and derivatives) I Pilocarpine and its salts 1 Pinaverium bromide 2 Polymyxin B and its salts and derivatives (for ophthalmic use) I Prasterone I Quinbolone I Ranitidine and its salts (except oral tablets in strengths of 75 mg or less) 1 Sex hormones (the exemption from requiring a prescription if sold for veterinary use does not apply to those listed separately elsewhere in this schedule and those listed in the drug schedules associated with the ( 'ontrollcd Drugs and Subsiances Ail', except those contained in an agricultural implant) 2 Sodium tetradecyl sulfate I Stanozolol 1 Stenbolone and its derivatives 2 Stramonium and its preparations, extracts, and compounds I Testosterone and its derivatives I Tetracycline and its salts and derivatives v (the exemption limn requiring a prescription if sold for veterinary use does not apply if sold as doxycycline for intramuscular administration in caged birds) 1 Tibolone 3 Tioconazole and its salts ( in preparations for topical or vaginal use) 1 Tioconazole and its salts (except in preparations for topical or vaginal use in humans) I Tiomesterone 1 Trenbolone and its derivatives I Tylosin and its salts and derivatives (except when sold for the treatment of chronic '1'he 'ontrolled Drugs and Substances Act replaced the Narcotic ('ontrol Act and certain parts of the Food and Drugs Act. For the list of exceptions, refer to the last pages of the "Extracts from Regulations to the / ood and Drugs Act" in the Information File Binder. otett- I 5/tmd 01.11I1,)X1) RES Our mission: Sale and effective pharmacy practice outcomes for the people of British ('olumbia.

13 SCHEDULE (continued) Page 7 colitis in dogs) 1 Vaccines (except brucellosis, equine influenza, leptospirosis, mink plasmacytosis and rabies) 1 Zeranui oteu- I 5/ttnd g1) RI Our mission: Sale and effective pharmacy practice outcomes lin. the people of British ('olumhia.